SEAPORT THERAPEUTICS Stock Price, News & Analysis
Company Description
SEAPORT THERAPEUTICS (NASDAQ: SPTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.0B, ranking #2,897 among all listed U.S. companies by market cap.
SPTX stock has declined 14.3% over the past year. Shares last traded at $17.00.
This page provides a comprehensive overview of SPTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SEAPORT THERAPEUTICS (SPTX) stock last traded at $17.00, down 14.31% from the previous close. Over the past 12 months, the stock has lost 14.3%. At a market capitalization of $1.0B, SPTX is classified as a small-cap stock with approximately 53.4M shares outstanding.
SPTX Rankings
Latest News
SEAPORT THERAPEUTICS has 1 recent news article, with the latest published 4 days ago. Key topics include IPO, offering. View all SPTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SPTX Company Profile & Sector Positioning
SEAPORT THERAPEUTICS (SPTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.